Evaluating BI 1015550 over at least 52 weeks | Clinical Research Studies Listing

Build status - In Progress

Recruiting

18 years - 99 years

All

1 Location

Brief description of study

This is a double-blind, placebo controlled study to assess the safety and efficacy of BI1015550 on patients with IPF. It is a phase 3 study and will including physical exams, a CT, questionnaires, safety lab samples, lung function testing, and ECGs.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Idiopathic Pulmonary Fibrosis,IPF
Age: 18 years - 99 years
Gender: All

Updated on 04 Aug 2024. Study ID: 852126

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

View email

Phone

View phone

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center

Evaluating BI 1015550 over at least 52 weeks in patients with Idiopathic Pulmonary Fibrosis (IPF)

Brief description of study

Eligibility of study

Find a site

Interested in the study